Clinical Trial Update: 5-HTP in Patients With IBD in Clinical and Biologic Remission:Effect on Fatigue Scores [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating 5-HTP in patients with inflammatory bowel disease in clinical and biologic remission to assess effects on fatigue scores.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Ulcerative Colitis

Drugs mentioned

• 5-HTP (5-hydroxytryptophan)

Snippet

Sponsor: University Hospital, Ghent | Conditions: Crohn Disease, Ulcerative Colitis | Phase 2 | Status: COMPLETED